Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550774

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550774

Human Milk Oligosaccharides Market, By Application, By Type, By Geography

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

The human milk oligosaccharides market is estimated to be valued at USD 298.6 Mn in 2024 and is expected to reach USD 770.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 298.6 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 14.50% 2031 Value Projection: US$ 770.5 Mn
Figure. Human Milk Oligosaccharides Market Share (%), By Region 2024
Human Milk Oligosaccharides Market - IMG1

Human milk oligosaccharides (HMOs) are complex sugars found in breastmilk that support the growth of beneficial gut bacteria in infants and provide protection against pathogenic bacteria. As the third most abundant solid component in breastmilk after lactose and fat, HMOs mimic components of the mucosal layer in the infant gut and prevent pathogens from attaching to and colonizing the intestinal wall. Research has shown that HMOs can promote brain development and stimulate immune cell development in infants. Due to their demonstrated prebiotic and nutritional properties similar to human breastmilk, HMOs are being incorporated into infant formula to deliver health benefits to bottle-fed babies.

Market Dynamics:

The global human milk oligosaccharides market is driven by growing awareness about the importance of HMOs in infant nutrition and development. As many mothers face difficulties in breastfeeding, the demand for HMO-fortified infant formula is increasing significantly. Major market players have developed technological capabilities to produce HMOs through the fermentation of various dairy and plant-based ingredients. However, the high costs involved in the production process pose a challenge to market growth. Ongoing research focused on reducing production costs could open up opportunities for the wider application of HMOs beyond infant nutrition in areas such as clinical nutrition, personal care, and supplemental food & beverages.

Key Features of the Study:

  • This report provides in-depth analysis of the global human milk oligosaccharides market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global human milk oligosaccharides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include ZuChem Inc., Merck & Co. Inc., Chr. Hansen Holding AS , Royal FrieslandCampina NV, BASF, IFF (DuPont Nutrition & Health), Gnubiotics, Inbiose NV, Carbosynth Holdings Limited, Royal DSM N.V, Kyowa Hakko Europe GmbH, Elicityl SA, FrieslandCampina Ingredients, Glycom A/S, Dextra Laboratories Limited, and Rajvi Enterprise
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global human milk oligosaccharides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human milk oligosaccharides market

Detailed Segmentation-

  • By Application:
    • Infant Formula
    • Dietary Supplements
    • Functional Food and Beverage
  • By Type:
    • 2'FL
    • 3'FL
    • 3'SL
    • 6'SL
    • LNT
    • LNnT
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • ZuChem Inc.
    • Merck & Co. Inc.
    • Chr. Hansen Holding AS
    • Royal FrieslandCampina NV
    • BASF
    • IFF (DuPont Nutrition & Health)
    • Gnubiotics
    • Inbiose NV
    • Carbosynth Holdings Limited
    • Royal DSM N.V
    • Kyowa Hakko Europe GmbH
    • Elicityl SA
    • FrieslandCampina Ingredients
    • Glycom A/S
    • Dextra Laboratories Limited
    • Rajvi Enterprise
Product Code: CMI5064

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Application
    • Market Snippet, By Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Mergers and Acquisitions

4. Global Human Milk Oligosaccharides Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overview
  • Factors Affecting the Global Human Milk Oligosaccharides Market
  • Impact Analysis

5. Global Human Milk Oligosaccharides Market, By Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Infant Formula
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • Functional Food and Beverage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends

6. Global Human Milk Oligosaccharides Market, By Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • 2'FL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • 3'FL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • 3'SL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • 6'SL
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • LNT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends
  • LNnT
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Mn)
    • Segment Trends

7. Global Human Milk Oligosaccharides Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024, 2027 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
  • North America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn))
    • Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, By Application, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Type, 2019 - 2031, (US$ Mn)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa

8. Competitive Landscape

  • Market Share Analysis
  • Company Profiles
    • ZuChem Inc.
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Merck & Co. Inc.
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Chr. Hansen Holding AS
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Royal FrieslandCampina NV
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • BASF
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • IFF (DuPont Nutrition & Health)
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Gnubiotics
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Inbiose NV
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Carbosynth Holdings Limited
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Royal DSM N.V
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Kyowa Hakko Europe GmbH
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Elicityl SA
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • FrieslandCampina Ingredients
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Glycom A/S
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Dextra Laboratories Limited
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates
    • Rajvi Enterprise
      • Company Overview
      • Application Portfolio
      • Recent Developments/Updates

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
    • Browse 25 market data tables* and 20 figures* on "Global Human Milk Oligosaccharides Market" - Global forecast to 2031.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!